Latest Blogs, Articles, and More
Ibrutinib becomes the first drug specifically approved for Waldenström’s macroglobulinemia (WM), two months ahead of expectations.
Every day, breast cancer researcher Edith Perez sets her mind on finding better treatments for the disease and conducting research aimed at improving patients' lives.
When motivating people to get screened for cancer, fear may not be the best way to do it.
The Food and Drug Administration is evaluating proposals for new indications for at least 17 oncology medicines, according to Friends of Cancer Research, an advocacy group that aims to get patients cutting-edge treatments as safely and quickly as possible.
An analysis of patients with advanced hepatocellular carcinoma and elevated AFP who received second-line Cyramza showed improved survival, according to data from the phase 3 REACH study.